DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lapachone is an investigational drug.
There have been 6 clinical trials for Lapachone. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2010.
The most common disease conditions in clinical trials are Metabolic Syndrome X, Pancreatic Neoplasms, and [disabled in preview]. The leading clinical trial sponsors are University of Texas Southwestern Medical Center, KT&G Life Sciences Corp, and KT&G Corporation.
Recent Clinical Trials for Lapachone
|ARQ761 + PARP Inhibitor in Refractory Solid Tumors||University of Texas Southwestern Medical Center||Phase 1|
|ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer||University of Texas Southwestern Medical Center||Phase 1|
|Clinical Trial of ARQ 761 in Advanced Solid Tumors||ArQule||Phase 1|